With thanks to our event hosts: 
The Medilink Midlands Strategic Innovation Gateways create an environment for innovation, knowledge exchange, business opportunities and networking.
Delivered in partnership with a select consortium of experts from academia, clinicians and industry, the Medilink Midlands Strategic Innovation Gateways (SIG) will help to create intelligence and data which will be used to inform policy making and influence national and regional strategies for the sector.
Medilink Midlands invites you to join the second in the series of SIG events, to expand your knowledge of the medtech space, specifically, the future of healthcare with Artificial Intelligence (AI).
As a region, the Midlands houses one of the greatest health and life sciences clusters and the largest number of medtech companies in the UK, with over 1,200 life sciences businesses supporting over 33,000 high skilled jobs, and an economy worth more than £200bn a year.
Home to rapidly growing cluster of digital health companies and more digital startups than any other UK area outside of London – the Midlands is the powerhouse for the medtech and life sciences industry.
This event offers a gateway to representatives who can offer support and guidance with medtech developments and innovations, connect you with academic, business and clinical communities to help forge collaborative partnerships.
Programme:
9:30am – Registrations and Refreshments
10:00am – Welcome and Introductions, Professor Philip Breedon, Professor of Smart Technologies, Nottingham Trent University and Chair of the MedTech Strategic Innovation Gateway
10:05am – Transforming Healthcare Through AI-Powered Innovation, Dr Junaid Arshad, Professor in Cyber Security, Birmingham City University
10:15am – AI and Intellectual Property in Healthcare, Simon Cooper, Managing Director, Adamson Jones
– Why does it matter?
– Opportunities and threats
– Recent legal developments, case studies and examples
– Recommendations
10:40am – Reimagining operating rooms with AI vision, Maks Kozarzewski, COO, VitVio
11:05am – Refreshments, Break and Networking
11:30am – AI Regulations and Medical Devices: Artificial Hope or Intelligent Solution, Richard Bassett, Principal Regulatory Consultant, DLRC
– Exploring various types of AI and their applications in healthcare
– Essential regulatory considerations for integrating AI into medical devices
– The impact of AI Act and Medical Device Legislation on AI-driven healthcare innovations
11:55 – Integrating AI and Human-Centred Design in Healthcare: A Path to Better Outcomes, James Lomas, Co-Founder/CTO, Blüm Health Ltd
12:20pm – Closing Remarks Professor Philip Breedon, Professor of Smart Technologies, Nottingham Trent University and Chair of the MedTech Strategic Innovation Gateway
12:30pm – Lunch and Networking
Cost and tickets:
Registrations are now closed. If you would like to book a ticket, please email events@medilinkmidlands.com.
£20 plus VAT for members of Medilink
£40 plus VAT for non-members
£10 plus VAT for students
To receive the member or student discount code email events@medilinkmidlands.com.
Please enter the code when you purchase your tickets and the amount will be amended automatically.
Speaker Profiles:
MedTech SIG Chair: Professor Philip Breedon, Professor of Smart Technologies, Nottingham Trent University
Philip holds multiple positions and interests surrounding medical technologies, with his research interests and latest projects centred on new and emerging technologies and materials, including surgical robotics, extended reality technologies and environments, the surgical pathway and investigative research related to the utilisation of ‘smart materials’ for medical applications.
Dr Junaid Arshad, Professor in Cyber Security, Birmingham City University
Junaid is a Professor in Cyber Security at Birmingham City University. He has 15 years of research experience and expertise in investigating and addressing cybersecurity challenges for diverse computing paradigms such as High Performance Computing, Cloud computing, IoT, and blockchain. He is actively engaged in investigating the opportunities and threats of Machine Learning and AI, exploring the use of AI-based systems to address specific challenges as well as security and trustworthiness of ML and AI systems.
Junaid is continuously engaged with businesses to support their needs especially with respect to digital transformation and trustworthy use of technological advancements to solve everyday problems. He has led number of projects in collaboration with industrial partners funded by Innovate UK and other third party funding agencies. He is currently leading BCU team for West Midlands Healthtech Innovation Accelerator (WMHTIA) project where the team is supporting 15+ Healthtech organisations within West Midlands region with their specific product development and technology enhancement needs, many of which are focused on leveraging AI and ML to advance their products.
Junaid is an alumnus of the Innovate UK & DCMS funded CyberASAP programme, commercially prototyping the CyMonD system for effective monitoring & defence of IoT-based systems against cyber-threats. Junaid has successfully achieved research funding from UK and overseas funding agencies, and has worked as a security specialist for a number of EU funded projects with experience of developing bespoke security solutions. Junaid has successfully published high quality research within cybersecurity and has more than 70 publications at high quality venues including journals, book chapters, conferences and workshops. He regularly serves on editorial boards and programme committees of different journals and conferences.
Simon Cooper, Managing Director, Adamson Jones
Simon is managing director of Adamson Jones, a dedicated firm of patent and trade mark attorneys within the professional services group Gateley.
Simon’s patent practice covers a wide range of different technologies, but with a particular focus on medical devices, including mechanical, electrical, and software-based technology for medical applications. Simon has particular experience working for successful, innovative manufacturers and spin-out companies, assisting his clients in navigating competitor IP rights, and creating patent, registered design and registered trade mark portfolios around valuable technology and product ranges.
Maks Kozarzewski, COO, VitVio
Maks is the COO at VitVio, a startup using computer vision and AI to make operating rooms more efficient. Before joining VitVio, Maks led UK’s top-ranked team competing in the SpaceX Hyperloop Pod Competition, gaining him Forbes “25 under 25” title for his contributions to the space. He also developed medical diagnostic devices at a leading technology consultancy and has experience in public policy. He holds a Mechanical Engineering degree from the University of Edinburgh.
Richard Bassett, Principal Regulatory Consultant, DLRC
Richard is a medical device quality and regulatory professional, with a comprehensive background encompassing the utilisation, research, and manufacturing of medical devices and in vitro diagnostics (IVDs). Currently serving as a Principal Regulatory Consultant at DLRC, a renowned regulatory affairs consultancy with a team of over 80 highly qualified regulatory professionals, Richard operates from the UK office, contributing to DLRC’s success in strategically located offices across the UK, Germany, and the US.
Richard brings over 14 years of extensive experience within the medical device industry. He has held roles including quality management, regulatory compliance, and clinical strategy development. His expertise extends to effective supplier engagement and guiding product development. Richard’s professional journey has traversed roles with a legal manufacturer, consultancy positions, and contributions to a Notified Body. Richard holds a master’s degree in molecular biology, complemented by a second master’s degree in medical law, which specifically focused on UK and EU Medical Device Regulations. His dedication to sharing and imparting his knowledge is evident through his five-year tenure as a lecturer on medical device regulatory affairs at Cambridge University, where he has made valuable contributions to the BioEnterprise MSc course. As a Principal Regulatory Consultant at DLRC, Richard continues to bring his wealth of knowledge and hands-on experience to navigate the complex landscape of medical device regulations, contributing to DLRC’s reputation as an award-winning consultancy.
James Lomas, Co-Founder/CTO, Blüm Health Ltd
James has demonstrated a diverse and impactful career spanning several key positions. With over a decade of experience, he has been pivotal in various leadership roles. At Blüm Heath, he currently holds the position of Co-Founder and Chief Technical & Product Officer since October 2019. In this capacity, he has built and advised the product and technical strategy, whilst growing and managing the respective teams.
James has previously worked in leadership roles within large tech companies, most recently at Blue Prism. Complex systems were a part of the Blue Prism software ecosystem, pioneering the category of Robotic Process Automation, a field recognised globally for its innovation, with Blue Prism being voted into the MIT top 50 smartest companies from 2016-2021. James has successfully coordinated and delivered product leadership, solution design and execution of the cloud portfolio of products during this period up until their acquisition by SS&C. He also championed and established the Design System with internal and external interactions within teams and customers for future products.
His expertise spans diverse sectors, including Finance, Venture Capital, Banking, FinTech, and Health Tech. His extensive experience in project leadership, coupled with his technical proficiency, has enabled him to drive innovation and growth within these organisations. In the Finance and Venture Capital sectors, he has collaborated with stakeholders to identify procedural frictions, commercial opportunities, and develop strategies aligning with market trends, innovation landscape, and financial goals. His contributions in Banking and FinTech involve developing technology-driven solutions to enhance financial services and customer experiences, while ensuring regulatory compliance. In Health Tech, as indicated by his work with clients like the NHS, he focuses on integrating technology to improve healthcare delivery and outcomes. His experience working with both public and private companies has given him a deep understanding of various organisational structures and market dynamics.
This event is in collaboration with:
